Back to List

Gilead Sciences, Inc.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead’s vision is to create a healthier world for all people and we pursue initiatives that help improve global health equity. It is our joint responsibility to create ways in which access to care and treatment can be achieved globally in partnership with governments, civil society and communities we serve.
Since 1987, Gilead has commercialized more than 25 innovative medicines, helping to transform treatment for people living with diseases such as HIV, viral hepatitis, COVID-19, neglected tropical diseases and cryptococcal meningitis around the world. More importantly, we aim for our contribution to go beyond medicines: our goal is to eliminate diseases and deliver meaningful impact backed up by rigorous assessment.